| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.413 | 7.962 | 9.127 | 13.683 | 15.732 | 13.814 | 19.820 | 22.994 | 29.467 |
| Total Income - EUR | - | 13.413 | 7.962 | 9.127 | 13.683 | 15.732 | 13.814 | 19.820 | 22.994 | 29.467 |
| Total Expenses - EUR | - | 5.573 | 8.377 | 7.014 | 10.378 | 13.141 | 12.858 | 15.019 | 14.200 | 11.408 |
| Gross Profit/Loss - EUR | - | 7.840 | -415 | 2.113 | 3.304 | 2.591 | 957 | 4.801 | 8.793 | 18.059 |
| Net Profit/Loss - EUR | - | 7.559 | -494 | 2.022 | 3.167 | 2.445 | 821 | 4.607 | 8.591 | 17.308 |
| Employees | - | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Amanamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 100 | 694 | 235 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 9.740 | 2.116 | 2.666 | 6.896 | 5.822 | 2.316 | 6.199 | 11.153 | 24.001 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.085 |
| Receivables | - | 471 | 883 | 860 | 3.139 | 1.775 | 1.395 | 4.944 | 9.454 | 21.290 |
| Cash | - | 9.269 | 1.232 | 1.806 | 3.757 | 4.047 | 921 | 1.255 | 1.699 | 1.626 |
| Shareholders Funds | - | 7.603 | -244 | 1.783 | 4.915 | 4.051 | 1.037 | 4.656 | 9.493 | 22.465 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.237 | 3.053 | 1.118 | 1.981 | 1.772 | 1.279 | 1.544 | 1.660 | 1.536 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amanamed Srl